Management of patients with obesity and noncommunicable diseases by primary health care physicians. Guidelines

These guidelines present an algorithm for managing patients with obesity and noncommunicable diseases in primary health care facilities. The presented algorithm includes measures aimed at assessing the patient's condition and comorbidities, developing individualized treatment plans and adjusting therapy, and regularly monitoring the therapy effectiveness. Key criteria for monitoring treatment effectiveness are presented to reduce the risk of complications and improve the overall quality of life and life expectancy of patients. The systematization and structuring of modern clinical guidelines and standards in terms of monitoring make this manual relevant, practice-­oriented, and useful for healthcare professionals. The inclusion of research data ensures the high effectiveness of the proposed approaches and their application in routine health practice.

These guidelines can be used by healthcare administrators, heads of primary care facilities and related departments.

1. Alferova VI, Mustafina SV. The prevalence of obesity in the adult population of the Russian Federation (literature review). Obesity and metabolism. 2022;19(1):96-105. (In Russ.) doi:10.14341/omet12809.

2. Bondareva EA, Troshina EA. Obesity. Reasons, features and prospects. Obesity and metabolism. 2024;21(2):174-87. (In Russ.) doi:10.14341/omet13055.

3. Dedov II, Shestakova MV, Melnichenko GA, et al. Interdisciplinary clinical practice guidelines "Management of obesity and its comorbidities". Obesity and metabolism. 2021; 18(1):5-99. (In Russ.) doi:10.14341/omet12714.

4. Drapkina OM, Kontsevaya AV, Kalinina AM, et al. Comorbidity of patients with non­com­mu­nicable diseases in general practice. Eurasian guidelines. Cardiovascular The­ra­py and Pre­ven­tion. 2024;23(3):3996. (In Russ.) doi:10.15829/1728-8800-2024-3996.

5. Drapkina OM, Karamnova NS, Kontsevaya AV, et al. Russian Society for the Prevention of Noncommunicable Diseases (ROPNIZ). Alimentary-­dependent risk factors for chronic non-communicable diseases and eating habits: dietary correction within the frame­work of pre­ven­tive counseling. Methodological Guidelines. Cardiovascular Therapy and Pre­ven­tion. 2021;20(5):2952. (In Russ.) doi:10.15829/1728-8800-2021-2952.

6. Drapkina OM, Kontsevaya AV, Kalinina AM, et al. 2022 Prevention of chronic non-communicable diseases in the Russian Federation. National guidelines. Cardiovascular Therapy and Prevention. 2022;21(4):3235. (In Russ.) doi:10.15829/1728-8800-2022-3235.

7. Schutz D, Busetto L, Dicker D, et al. European Practical and Patient-­Centred Guide­lines for Adult Obesity Management in Primary Care. Obes Facts. 2019;12(1):40-66. doi:10.1159/000496183.

8. Shepel RN, Ipatov PV, Drozdova LYu, et al. Algorithm of appointment (examination; con­sul­tation) of patients under follow-up care by a general practitioner. Cardio­vas­cular Therapy and Prevention. 2025;24(3):4372. (In Russ.) doi:10.15829/1728-8800-2025-4372.

9. Ard JD, Lewis KH, Cohen SS, et al. Differences in treatment response to a total diet replacement intervention versus a food-based intervention: A secondary analysis of the OPTIWIN trial. Obes Sci Pract. 2020:1-10. doi:10.1002/osp4.444.

10. Ard J, Lewis K, Rothberg A, et al. Effectiveness of a total meal replacement program on weight loss: Results from the OPTIWIN study. Obesity. 2018;27:22-9. doi:10.1002/oby.22303.

11. Steven S, Hollingsworth KG, Al-­Mrabeh A, et al. Very Low-­Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders. Diabetes Care. 2016;39(5):808-15. doi:10.2337/dc15-1942. Erratum in: Diabetes Care. 2018;41(6):1321. doi:10.2337/dc18-er06.

12. Colles SL, Dixon JB, Marks P, et al. Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal fat by serial imaging. Am J Clin Nutr. 2006;84(2):304-11. doi:10.1093/ajcn/84.1.304.

13. Bischoff SC, Damms-­Machado A, Betz C, et al. Multicenter evaluation of an interdisciplinary 52-week weight loss program for obesity with regard to body weight, comorbidities and quality of life--a prospective study. Int J Obes (Lond). 2012;36(4):614-24. doi:10.1038/ijo.2011.107.

14. Roesler A, Marshall S, Rahimi-­Ardabili H, et al. Choosing and following a very low calorie diet program in Australia: A quasi-­mixed methods study to understand experiences, barriers, and facilitators in a self-initiated environment. Nutr Diet. 2020:1-16. doi:10.1111/1747-0080.12645.

15. Drapkina OM, Mokrysheva NG, Eliashevich SO, et al. Management of overweight and obese patients without noncommunicable diseases in primary care facilities. Guidelines. Primary Health Care (Russian Federation). 2025;2(3):115-134. (In Russ.) doi:10.15829/3034-4123-2025-77. EDN: BNQMFG

16. Karamnova NS, Izmailova OV, Kalinina AM, et al. Methodical manual on the quan­ti­tative assessment of food consumed “Atlas of portions of food and dishes". Polygraphy for Business LLC, 2018. p. 110. (In Russ.) ISBN: 978-5-600-02141-9.

17. Mozaffarian D, Agarwal M, Aggarwal M, et al. Nutritional priorities to support GLP-1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Obesity (Silver Spring). 2025;129. doi:10.1002/oby.24336.

18. Lee CY. A Combination of Glucagon-­Like Peptide-1 Receptor Agonist and Dietary Intervention Could Be a Promising Approach for Obesity Treatment. Front. Endocrinol. 2021;2:748477. doi:10.3389/fendo.2021.748477.

19. Drapkina OM, Mokrysheva NG, Shestakova MV, et al. Outpatient follow-up of patients with prediabetes by a general practitioner in primary health care. Methodological recommendations (edition 2). Moscow: ROPNIZ, 2024. (In Russ.) ISBN: 978-5-6052598-2-4. doi:10.15829/ROPNIZ-d100-2024.

20. Drapkina OM, Svishcheva AA, Lavrenova EA, Shepel RN. Implementation of programs for early detection of type 2 diabetes mellitus and dispensary monitoring of patients with this disease in health care systems: international and national experience. Primary Health Care (Russian Federation). 2025;2(2):34-44. (In Russ.) doi:10.15829/3034-4123-2025-56.

21. Drapkina OM, Boytsov SA, Atyunina IV, et al. Outpatient follow-up of hypertensive pa­tients by a primary care physician. Guidelines. Primary Health Care (Russian Federation). 2025;2(2):206-236. (In Russ.) doi:10.15829/3034-4123-2025-55. EDN: RRZSLK

22. Mantovani A, Csermely A, Petracca G, et al. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2021;6(11):903-13. doi:10.1016/S2468-1253(21)00308-3.

23. Bischoff SC, Barazzoni R, Busetto L, et al. European guideline on obesity care in patients with gastrointestinal and liver diseases — Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline. United European Gastroenterol J. 2022;10(7):663-720. doi:10.1002/ueg2.12280.

24. Drapkina OM, Avdeev SN, Smirnova MI, et al. Outpatient monitoring of patients with chronic obstructive pulmonary disease by a primary care physician. Guidelines. Primary Health Care (Russian Federation). 2025;2(2):135-64. (In Russ.) doi:10.15829/3034-4123-2025-42. EDN: YNVNQE.

25. Drapkina OM, Avdeev SN, Smirnova MI, et al. Outpatient follow-up of patients with asthma by a primary care physician. Guidelines. Primary Health Care (Russian Fe­de­ra­ti­on). 2025;2(2):165-205. (In Russ.) doi:10.15829/3034-4123-2025-43. EDN: YQNQOU

26. Drapkina OM, Drozdova LYu, Kontsevaya AV, et al. Providing medical care to patients with risk factors for developing chronic noncommunicable diseases in adult health centers. Methodological recommendations. M.: ROPNIZ, LLC "SILICEA-POLYGRAPH" 2025. 164 p. (In Russ.) ISBN: 978-5-6053845-8-8. doi:10.15829/ROPNIZ-d108-2025. EDN: HKMNQW

27. Lukina YuV, Kutishenko NP, Martsevich SYu, Drapkina OM. The Questionnaire Survey Me­thod in Medicine on the Example of Treatment Adherence Scales. Ratio­nal Phar­ma­co­the­rapy in Cardiology. 2021;17(4):576-83. (In Russ.) doi:10.20996/1819-6446-2021-08-02.